Systemic a-synuclein injection triggers selective neuronal pathology as seen in patients with Parkinson's disease. (2021)
Attributed to:
Wellcome Trust MRC Cambridge Stem Cell Institute
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.46150
Publication URI: https://www.repository.cam.ac.uk/handle/1810/299088
Type: Journal Article/Review